Physician profile
Angela L Huff
NPI 1821161050
$10,663.17
in general payments reported to CMS, 2019-2025
40 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,476 · 2020: $2,756 · 2021: $3,242 · 2022: $189.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $1,745.62 | 2019-2022 | |
| Supernus Pharmaceuticals, INC. | $1,160.19 | 2019-2021 | |
| Acadia Pharmaceuticals INC | $829.61 | 2019-2022 | |
| Genzyme Corporation | $754.67 | 2019-2021 | |
| Biogen, INC. | $492.70 | 2019-2021 | |
| Mdd US Operations, LLC | $484.83 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $480.18 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $473.38 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $393.86 | 2019-2022 | |
| Ucb, INC. | $305.43 | 2019-2022 | |
| Abbvie INC. | $296.68 | 2021-2022 | |
| Neurocrine Biosciences, INC. | $290.23 | 2019-2020 | |
| Lilly USA, LLC | $289.98 | 2019-2022 | |
| Novo Nordisk INC | $246.38 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $216.37 | 2021 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acorda Therapeutics, INC | $196.72 | 2019-2021 | |
| Allergan, INC. | $169.67 | 2020 | |
| Kyowa Kirin, INC. | $168.30 | 2020-2021 | |
| Alexion Pharmaceuticals, INC. | $151.68 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $143.62 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $139.93 | 2019-2021 | |
| Genentech USA, INC. | $131.12 | 2019-2021 | |
| Neurelis, INC. | $125.41 | 2020-2021 | |
| Amgen INC. | $122.56 | 2019-2021 | |
| Upsher-Smith Laboratories LLC | $116.40 | 2020-2021 | |
| Sk Life Science, INC. | $98.48 | 2020-2021 | |
| Avanir Pharmaceuticals, INC. | $93.08 | 2019 | |
| Adamas Pharmaceuticals, INC. | $79.42 | 2019-2021 | |
| Lundbeck LLC | $69.46 | 2021-2022 | |
| Alfasigma USA, INC. | $68.96 | 2021-2022 | |
| Arbor Pharmaceuticals, INC. | $60.48 | 2021 | |
| Aprecia Pharmaceuticals, LLC | $59.05 | 2019-2020 | |
| Amneal Pharmaceuticals LLC | $51.44 | 2019 | |
| Ge Healthcare | $39.81 | 2019 | |
| Celgene Corporation | $38.13 | 2020-2021 | |
| Boston Scientific Corporation | $21.55 | 2020 | |
| Eisai INC. | $19.59 | 2019 | |
| Vertical Pharmaceuticals, LLC | $14.80 | 2019 | |
| Dynasplint Systems INC. | $13.14 | 2019 | |
| Sanofi-Aventis U.S. LLC | $10.26 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Huff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.